- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07608783
Clinical Evaluation of Nano-Hydroxyapatite as an Adjunctive to Minimally Invasive Non-Surgical Technique in the Treatment of Deep Intra-bony Defects (MINST)
27 maj 2026 uppdaterad av: Salah Eddin Sheet, Cairo University
Clinical Evaluation of Nano-Hydroxyapatite as an Adjunctive to Minimally Invasive Non-Surgical Technique in the Treatment of Deep Intra-bony Defects: A Randomized Controlled Clinical Trial
This randomized controlled clinical trial aims to evaluate the effectiveness of using nano-hydroxyapatite (nHA) gel alongside a minimally invasive non-surgical technique (MINST) to treat deep intra-bony defects in patients with Stage III periodontitis.
While MINST is an effective method for cleaning deep periodontal pockets without the need for traditional surgery, the addition of nHA may further enhance soft tissue healing, improve cellular interaction, and promote bone regeneration.
Participants in the study will be randomly assigned to one of two groups.
The test group will receive the MINST procedure combined with the application of nHA gel directly into the periodontal pocket, while the control group will receive the MINST procedure alone.
The primary goal of the study is to measure the decrease in probing pocket depth over a 6-month follow-up period to determine if the adjunctive use of nHA provides superior clinical outcomes compared to non-surgical treatment alone.
Studieöversikt
Status
Aktiv, inte rekryterande
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
28
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Cairo, Egypten, 11511
- Oral Medicine and Periodontology department, Faculty of Dentistry - Cairo University.
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria:
- Systemically healthy adults aged 18-65 years.
- No history of systemic diseases affecting periodontal status or bone metabolism (e.g., uncontrolled diabetes, osteoporosis).
- Diagnosed with Stage III periodontitis according to the 2018 classification of periodontal diseases (with interdental CAL ≥5 mm, probing depth ≥6 mm).
- Presence of at least one deep intra-bony defect (≥3 mm defect depth) in a single-rooted or multi-rooted tooth.
- Willingness to participate and sign informed consent.
Exclusion Criteria:
- Immunocompromised patients, uncontrolled diabetics (HbA1c ≥ 7.0%), or individuals with autoimmune disorders.
- History of malignancy or chemotherapy/radiation in the past year.
- Use of bisphosphonates, corticosteroids, immunosuppressive antibiotics or anti-inflammatory agents within 6 months before periodontal therapy.
- Smokers (≥ 10 cigarettes per day).
- Pregnant or breastfeeding women, confirmed via medical history and/or test.
- Receipt of periodontal surgery or nonsurgical treatment within the last 6 months.
- Teeth with peri-apical pathology, acute abscess, or grade III mobility.
- Multi-rooted teeth with class II and class III furcation defects.
- Third molars.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: MINST alone
Participants receive the minimally invasive non-surgical technique (MINST) alone without adjunctive treatment
|
Subgingival debridement using thin ultrasonic tips and Gracey mini-curettes under magnification, deliberately avoiding subgingival rinsing to support blood clot stabilization
|
|
Experimentell: MINST + nano-hydroxyapatite
Participants receive MINST combined with the adjunctive application of nano-hydroxyapatite gel
|
Subgingival debridement using thin ultrasonic tips and Gracey mini-curettes under magnification, deliberately avoiding subgingival rinsing to support blood clot stabilization
A single dose of nano-hydroxyapatite (nHA) gel applied subgingivally directly into the periodontal pocket associated with the intrabony defect immediately following debridement
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Probing Pocket Depth (PPD)
Tidsram: 6 months
|
Measured in millimeters (mm) using a manual periodontal probe (UNC-15)
|
6 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Clinical Attachment Level (CAL)
Tidsram: 1, 3, and 6 months post-treatment.
|
Measured in millimeters (mm) using a manual periodontal probe (UNC-15).
|
1, 3, and 6 months post-treatment.
|
|
Gingival Recession (GR)
Tidsram: 1, 3, and 6 months post-treatment.
|
Measured in millimeters (mm) using a manual periodontal probe (UNC-15).
|
1, 3, and 6 months post-treatment.
|
|
Radiographic Defect Angle (RDA)
Tidsram: 1, 3, and 6 months post-treatment.
|
Measured in degrees (°) utilizing standardized periapical radiographs and measurement software.
|
1, 3, and 6 months post-treatment.
|
|
Patient Satisfaction
Tidsram: 1, 3, and 6 months post-treatment.
|
Assessed via a structured questionnaire utilizing a Likert scale.
The scale ranges from 1 to 5, where 1 indicates "Very Dissatisfied" and 5 indicates "Very Satisfied," meaning higher scores represent a better outcome.
|
1, 3, and 6 months post-treatment.
|
|
Full-Mouth Plaque Score (FMPS)
Tidsram: 1, 3, and 6 months post-treatment.
|
Assessed as a percentage (%) using the Visible Plaque Index (O'Leary et al.).
The index ranges from a minimum of 0% to a maximum of 100%.
Higher percentages indicate a greater presence of plaque, representing a worse clinical outcome.
|
1, 3, and 6 months post-treatment.
|
|
Full-Mouth Bleeding Score (FMBS)
Tidsram: 1, 3, and 6 months post-treatment.
|
Assessed as a percentage (%) using the Gingival Bleeding Index (Ainamo & Bay).
The index ranges from a minimum of 0% to a maximum of 100%.
Higher percentages indicate more widespread gingival bleeding, representing a worse clinical outcome.
|
1, 3, and 6 months post-treatment.
|
|
Cost Effectiveness based on Clinical Attachment Level (CAL)
Tidsram: 6 months post-treatment.
|
Evaluated using the cost-effectiveness ratio (CER) and incremental cost-effectiveness ratio (ICER), based on the cost in USD per millimeter (mm) of CAL improvement.
|
6 months post-treatment.
|
|
Cost Effectiveness based on Probing Pocket Depth (PPD)
Tidsram: 6 months post-treatment.
|
Evaluated using the cost-effectiveness ratio (CER) and incremental cost-effectiveness ratio (ICER), based on the cost in USD per millimeter (mm) of PPD improvement.
|
6 months post-treatment.
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
1 juli 2025
Primärt slutförande (Beräknad)
1 augusti 2026
Avslutad studie (Beräknad)
28 augusti 2026
Studieregistreringsdatum
Först inskickad
20 maj 2026
Först inskickad som uppfyllde QC-kriterierna
20 maj 2026
Första postat (Faktisk)
27 maj 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
29 maj 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
27 maj 2026
Senast verifierad
1 maj 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- PER 3 - 3 - 2
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .